Home/Filings/4/0001209191-23-016041
4//SEC Filing

KAKKIS EMIL D 4

Accession 0001209191-23-016041

CIK 0001515673other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 7:52 PM ET

Size

12.5 KB

Accession

0001209191-23-016041

Insider Transaction Report

Form 4
Period: 2023-03-01
KAKKIS EMIL D
DirectorPresident & CEO10% Owner
Transactions
  • Award

    Common Stock

    2023-03-01+46,200615,606 total
  • Award

    Stock Option (Right to Buy)

    2023-03-01+83,50083,500 total
    Exercise: $45.65Exp: 2033-03-01Common Stock (83,500 underlying)
  • Award

    Common Stock

    2023-03-01+8,716569,406 total
  • Tax Payment

    Common Stock

    2023-03-01$45.65/sh16,140$736,791599,176 total
Holdings
  • Common Stock

    (indirect: By Trust)
    2,263,985
Footnotes (6)
  • [F1]Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
  • [F2]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
  • [F3]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
  • [F4]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  • [F5]Reflects transfer of directly owned shares of common stock from the Reporting Person to a trust indirectly held by the Reporting Person that have taken place since the most recent prior report on Form 4.
  • [F6]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001248093

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:52 PM ET
Size
12.5 KB